New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa | |
Zhang, Yu; Guo, Lingli; Yang, Guangmei; Guo, Feng; Di, Yingtong; Li, Shunlin; Chen, Duozhi; Hao, Xiaojiang | |
2015 | |
发表期刊 | FITOTERAPIA |
卷号 | 100页码:150-155 |
摘要 | Ten vobasinyl-ibogan type bisindole alkaloids, including three new ones, tabercorines A-C (1-3), and a new natural product, 17-acetyl-tabemaecorymbosine A (4), were isolated from the twigs and leaves of Tabernaemontana coymbosa. Their structures were elucidated on the basis of spectroscopic data, and the NMR data of 17-acetyl-tabemaecorymbosine A (4) was assigned and reported for the first time. The absolute configurations of 1-4 were determined by CD exciton chirality method. All new compounds were evaluated for in vitro cytotoxicity against various human cancer cell lines. Compounds 1 and 4 showed significant inhibitory effects with IC50 values comparable to those of cisplatin. (C) 2014 Elsevier B.V. All rights reserved. |
关键词 | Tabernaemontana Corymbosa Bisindole Alkaloids Tabercorines A-c Cytotoxicity |
DOI | 10.1016/j.fitote.2014.11.016 |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000349881300019 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/20431 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Yu,Guo, Lingli,Yang, Guangmei,et al. New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa[J]. FITOTERAPIA,2015,100:150-155. |
APA | Zhang, Yu.,Guo, Lingli.,Yang, Guangmei.,Guo, Feng.,Di, Yingtong.,...&Hao, Xiaojiang.(2015).New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa.FITOTERAPIA,100,150-155. |
MLA | Zhang, Yu,et al."New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa".FITOTERAPIA 100(2015):150-155. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
1-s2.0-S0367326X1400(553KB) | 开放获取 | CC BY-NC-ND | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论